Kerstin Michalski

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Kerstin Michalski, Juri Ruf, Christian Goetz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 114 citations · Full text

Assessing Response to ¹⁷⁷Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria

Kerstin Michalski, Claudius Klein, Tonio Brüggemann et al. · Journal of Nuclear Medicine · 2021 · 43 citations · Full text

Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors

Aleksander Kosmala, Sebastian E. Serfling, Wiebke Schlötelburg et al. · Clinical Nuclear Medicine · 2022 · 39 citations · Full text

SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T

Philipp E. Hartrampf, Thomas Hüttmann, Anna Katharina Seitz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 33 citations · Full text

Prognostic Value of Tumor Volume Assessment on PSMA PET After¹⁷⁷Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0

Felix Kind, Ann-Christin Eder, Cordula A. Jilg et al. · Journal of Nuclear Medicine · 2022 · 29 citations · Full text